ZOAVE
DEAD

Serial Number

97171522

Owner

Teva Pharmaceuticals USA, Inc.

Attorney

Laurence Rickles

Filing Date

Dec 14, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ZOAVE Trademark

Serial Number: 97171522

ZOAVE is a trademark filed by Teva Pharmaceuticals USA, Inc. on December 14, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Teva Pharmaceuticals USA, Inc. (585 trademarks)

650 Cathill Road
Sellersville, PA 18960

Entity Type: 03

Trademark Details

Filing Date

December 14, 2021

Registration Date

Not Registered

Published for Opposition

July 5, 2022

Goods & Services

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the following systems and organs: autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, integumentary system diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, contraception, drug dependence, fertility disorders, hormone replacement, infectious diseases due to bacteria, viruses, fungi, parasites, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 6, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 6, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 23, 2025 EXRA
SOU EXTENSION 5 GRANTED
Apr 22, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 21, 2025 AITU
SOU EXTENSION 5 FILED
Jan 22, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 22, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2024 EXRA
SOU EXTENSION 4 GRANTED
Aug 19, 2024 EX4G
SOU EXTENSION 4 FILED
Aug 19, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 19, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2024 EXRA
SOU EXTENSION 3 GRANTED
Feb 27, 2024 EX3G
SOU EXTENSION 3 FILED
Feb 27, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 27, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 18, 2023 EXRA
SOU EXTENSION 2 GRANTED
Aug 16, 2023 EX2G
SOU EXTENSION 2 FILED
Aug 16, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 16, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 16, 2023 EXRA
SOU EXTENSION 1 GRANTED
Feb 14, 2023 EX1G
SOU EXTENSION 1 FILED
Feb 14, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 14, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 30, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 5, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 5, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 15, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 1, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 1, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 1, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 1, 2022 CNEA
ASSIGNED TO EXAMINER
May 25, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2021 NWOS
NEW APPLICATION ENTERED
Dec 17, 2021 NWAP